Herpes Cure Advocacy is very pleased to announce that the organization has been awarded grant funding from GSK to support it’s organizational capacity. Additional partners for supporting organizational capacity are being sought.
Supporting organizational capacity allows HCA to continue to advance it’s mission of eradicating the world of herpes simplex virus types 1 and 2 with professional resources.
We’re extremely grateful to one of the world’s largest pharmaceutical companies for believing in the value of Herpes Cure Advocacy and increasing our capacity to do our work. Herpes is a critical and underappreciated disease globally. We need resources to address it and these funds will make a significant impact for HCA to continue to advance our mission.
– Dr. Jeffrey Klausner, HCA Board President
With these funds, HCA can continue to advocate for change, engage patients, researchers and healthcare professionals, and will continue to change the field for HSV with professional strategies and resources.
Since it’s founding in 2022, Herpes Cure Advocacy has made significant advances to increase private and public investment in clinical research for Herpes Simplex. Advocacy wins include:
- Federal Government Action requiring the Department of Health and Human Services (HHS) to develop a National Strategy for herpes
- $250,000 in funding to HHS for strategy development
- In November 2022, the National Institutes of Health (NIH) convened a 2-day workshop on herpes cure, vaccine, and treatment research
- In 2023, the NIH released a 5-year HSV research strategy
- In December 2023, based upon clinical and laboratory data provided by HCA, the Food and Drug Administration (FDA) issued a safety communication about the poor performance of herpes simplex virus antibody tests
- In February 2024, the Office of the Assistant Secretary of Health released a draft addendum to the National STI Strategy addressing herpes
- Finally, HCA prompted the CDC to undertake efforts to evaluate the burden of neonatal herpes and consider making it a nationally notifiable condition
Additional partners are needed for the Capacity Building program at HCA. Want to help? Have questions? Please email info@herpescureadvocacy.com to learn more.